insights_auto
Why is SABS down ၃.၉၀%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
၂.၉၆ US$
arrow_downward
-၃.၉၀%(-၀.၁၂) 1D
နို ၁၃, GMT-၅ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
၃.၀၈ US$
High
၃.၁၅ US$
Low
၂.၈၅ US$
Mkt. cap
၂၆.၆၇ ကုဋေ
Avg. vol.
၇.၀၀ သိန်း
Volume
၆.၀၀
52-wk high
၅.၁၅ US$
52-wk low
၂.၄၄ US$
EPS
-၀.၉၃ US$
Beta
၀.၆၇
Shares outstanding
၉.၀၁ ကုဋေ
No. of employees
၈၆
Open
၃.၀၈ US$
High
၃.၁၅ US$
Low
၂.၈၅ US$
Mkt. cap
၂၆.၆၇ ကုဋေ
Avg. vol.
၇.၀၀ သိန်း
Volume
၆.၀၀
52-wk high
၅.၁၅ US$
52-wk low
၂.၄၄ US$
EPS
-၀.၉၃ US$
Beta
၀.၆၇
Shares outstanding
၉.၀၁ ကုဋေ
No. of employees
၈၆
News stories
From web sources and news partners
marketscreener.com
·
ပြီးခဲ့သည့် ၅၃ မိနစ်
Live Oak Acquisition Corp. VI(NasdaqGM: LOVI) added to NASDAQ Composite Index
Cryptonews.net
·
ပြီးခဲ့သည့် ၁၉ မိနစ်
Drakewell Introduces Hedged S&P 500 Token
US News Money
·
ပြီးခဲ့သည့် ၄၁ မိနစ်
S&P 500, Nasdaq Futures Slide as Nvidia Earnings, Anthropic Debut Loom
Business Insider
·
ပြီးခဲ့သည့် ၁ နာရီ
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
About SAB Biotherapeutics Inc
CEO-
Employees၈၆
Founded၂၀၁၄
HeadquartersMiami Beach, ဖလော်ရီဒါပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websitesab.bio